Franklin Resources
ALDR

Franklin Resources’s Alder Biopharmaceuticals ALDR Stock Holding History

Franklin Resources’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-725,000
Closed -$13.7M – 1604
2019
Q3 		$13.7M Hold
725,000
– – 0.01% 824
2019
Q2 		$8.53M Hold
725,000
– – ﹤0.01% 931
2019
Q1 		$9.9M Buy
+725,000
New +$9.39M 0.01% 880
2017
Q2 		– Sell
-244,600
Closed -$5.09M – 1551
2017
Q1 		$5.09M Hold
244,600
– – ﹤0.01% 1103
2016
Q4 		$5.09M Sell
244,600
-5,400
-2% -$140K ﹤0.01% 1081
2016
Q3 		$8.19M Hold
250,000
– – ﹤0.01% 1012
2016
Q2 		$6.24M Buy
+250,000
New +$6.76M ﹤0.01% 1063
2015
Q1 		– Sell
-629,472
Closed -$18.3M – 1636
2014
Q4 		$18.3M Sell
629,472
-40,728
-6% -$731K 0.01% 898
2014
Q3 		$8.5M Sell
670,200
-150,300
-18% -$2.27M ﹤0.01% 1073
2014
Q2 		$16.5M Buy
+820,500
New +$11.6M 0.01% 933

Franklin Resources's ALDR Position: Q4 2019 in Review

Franklin Resources sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 725,000 shares — an estimated $13.7M sold.

Franklin Resources first reported a position in ALDR in Q2 2014 and held it in 10 quarters. The position peaked at $18.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

  • Franklin Resources reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Franklin Resources sold 725,000 Alder Biopharmaceuticals shares in Q4 2019, an estimated $13.7M.
  • Franklin Resources first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 10 quarters.
  • Franklin Resources's Alder Biopharmaceuticals position peaked at $18.3M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Franklin Resources's 13F filing for Q4 2019, filed 12 Feb 2020.